120 related articles for article (PubMed ID: 21324492)
1. CpG ODN, Toll like receptor (TLR)-9 agonist, inhibits metastatic colon adenocarcinoma in a murine hepatic tumor model.
Kim IY; Yan X; Tohme S; Ahmed A; Cordon-Cardo C; Shantha Kumara HM; Kim SK; Whelan RL
J Surg Res; 2012 May; 174(2):284-90. PubMed ID: 21324492
[TBL] [Abstract][Full Text] [Related]
2. CpG-ODN-based immunotherapy is effective in controlling the growth of metastasized tumor cells.
Kim HA; Ko HM; Ju HW; Kim KJ; Roh SG; Lee HK; Im SY
Cancer Lett; 2009 Feb; 274(1):160-4. PubMed ID: 18952369
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic effects and mechanisms of CpG oligodeoxynucleotides in mice infected with Mycobacterium tuberculosis].
Ren T; Li CY; Cai YY; Jin ML; Hu YW; Yuan ZH; Tian M; Zhao B
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Feb; 29(2):87-91. PubMed ID: 16677448
[TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors.
Stoeltzing O; Ahmad SA; Liu W; McCarty MF; Wey JS; Parikh AA; Fan F; Reinmuth N; Kawaguchi M; Bucana CD; Ellis LM
Cancer Res; 2003 Jun; 63(12):3370-7. PubMed ID: 12810673
[TBL] [Abstract][Full Text] [Related]
5. TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effects.
Sommariva M; De Cecco L; De Cesare M; Sfondrini L; Ménard S; Melani C; Delia D; Zaffaroni N; Pratesi G; Uva V; Tagliabue E; Balsari A
Cancer Res; 2011 Oct; 71(20):6382-90. PubMed ID: 21878529
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
Wai PY; Mi Z; Guo H; Sarraf-Yazdi S; Gao C; Wei J; Marroquin CE; Clary B; Kuo PC
Carcinogenesis; 2005 Apr; 26(4):741-51. PubMed ID: 15661802
[TBL] [Abstract][Full Text] [Related]
7. Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapy.
Heckelsmiller K; Beck S; Rall K; Sipos B; Schlamp A; Tuma E; Rothenfusser S; Endres S; Hartmann G
Eur J Immunol; 2002 Nov; 32(11):3235-45. PubMed ID: 12555669
[TBL] [Abstract][Full Text] [Related]
8. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
Mason KA; Ariga H; Neal R; Valdecanas D; Hunter N; Krieg AM; Whisnant JK; Milas L
Clin Cancer Res; 2005 Jan; 11(1):361-9. PubMed ID: 15671567
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous delivery of doxorubicin and immunostimulatory CpG motif to tumors using a plasmid DNA/doxorubicin complex in mice.
Mizuno Y; Naoi T; Nishikawa M; Rattanakiat S; Hamaguchi N; Hashida M; Takakura Y
J Control Release; 2010 Jan; 141(2):252-9. PubMed ID: 19778560
[TBL] [Abstract][Full Text] [Related]
10. [A study on the mechanisms of mycobacterial clearance induced by CpG-oligodeoxynucleotides in mice].
Ren T; Liang YJ; Cai YY; Li CY; Mei J; Yuan ZH; Tao MF; Tian M; Zhao B
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jan; 31(1):46-50. PubMed ID: 18366907
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect of angiogenesis inhibitor YH-16 on liver metastases from colorectal cancer].
Zhou ZW; Wan DS; Wang GQ; Ren JQ; Lu ZH; Lin SX; Tang SX; Ye YL; Chen G
Ai Zheng; 2006 Jul; 25(7):818-22. PubMed ID: 16831270
[TBL] [Abstract][Full Text] [Related]
12. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.
Wu Y; Yakar S; Zhao L; Hennighausen L; LeRoith D
Cancer Res; 2002 Feb; 62(4):1030-5. PubMed ID: 11861378
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic and immunological effects of microwave ablation combined with CpG ODN on transplanted colon carcinoma in mice].
Zou N; Li XF; Ding WM; Lai QH; Zhang JR
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):984-8. PubMed ID: 20501375
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A
Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466
[TBL] [Abstract][Full Text] [Related]
15. Combinatorial therapy for liver metastatic colon cancer: dendritic cell vaccine and low-dose agonistic anti-4-1BB antibody co-stimulatory signal.
Lee H; Park HJ; Sohn HJ; Kim JM; Kim SJ
J Surg Res; 2011 Jul; 169(1):e43-50. PubMed ID: 21571303
[TBL] [Abstract][Full Text] [Related]
16. Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells.
Kitakata H; Nemoto-Sasaki Y; Takahashi Y; Kondo T; Mai M; Mukaida N
Cancer Res; 2002 Nov; 62(22):6682-7. PubMed ID: 12438267
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effect to IL-12 administration into the portal vein on murine liver metastasis.
Su W; Kitagawa T; Ito T; Oyama T; Lee CM; Kim YK; Matsuda H
J Hepatobiliary Pancreat Surg; 2002; 9(4):503-10. PubMed ID: 12483274
[TBL] [Abstract][Full Text] [Related]
18. Two distinct pathways of immuno-modulation improve potency of p53 immunization in rejecting established tumors.
Daftarian P; Song GY; Ali S; Faynsod M; Longmate J; Diamond DJ; Ellenhorn JD
Cancer Res; 2004 Aug; 64(15):5407-14. PubMed ID: 15289349
[TBL] [Abstract][Full Text] [Related]
19. Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice.
Pearlstein E; Ambrogio C; Karpatkin S
Cancer Res; 1984 Sep; 44(9):3884-7. PubMed ID: 6744304
[TBL] [Abstract][Full Text] [Related]
20. AsGM1+ NK cells prevent metastasis of invading LD-MCA-38 tumor cells in the nude mouse.
Volpe CM; Mehta N; Kim U; Hordines J; Doerr RJ; Cohen SA
J Surg Res; 1999 Jun; 84(2):157-61. PubMed ID: 10357913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
